A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification
- 7 September 2005
- journal article
- case report
- Published by Springer Nature in Human Genetics
- Vol. 118 (2), 261-266
- https://doi.org/10.1007/s00439-005-0026-8
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemiaHuman Molecular Genetics, 2004
- Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosisNature Genetics, 2004
- Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolismJournal of Clinical Investigation, 2004
- The phosphatonin pathway: New insights in phosphate homeostasisKidney International, 2004
- All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferasesGlycobiology, 2002
- Fibroblast Growth Factor (FGF)-23 Inhibits Renal Phosphate Reabsorption by Activation of the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 2002
- PROPOSAL FOR A PATHOGENESIS‐BASED CLASSIFICATION OF TUMORAL CALCINOSISInternational Journal of Dermatology, 1996
- Tumoral calcinosis revisited ? common and uncommon featuresEuropean Journal of Pediatrics, 1988
- NOMOGRAM FOR DERIVATION OF RENAL THRESHOLD PHOSPHATE CONCENTRATIONThe Lancet, 1975
- Tumoral Calcinosis--an Unrecognized DiseaseBMJ, 1969